Package 67296-2164-1

{"route": ["SUBLINGUAL"], "spl_id": "45abede5-7ceb-60e1-e063-6394a90a9a4a", "openfda": {"upc": ["0342858602037", "0342858601030"], "unii": ["56W8MW3EN1", "5Q187997EE"], "rxcui": ["351267"], "spl_set_id": ["374530e2-3b2e-77d7-e063-6394a90a37c9"], "manufacturer_name": ["Redpharm Drug"]}, "finished": true, "packaging": [{"sample": false, "description": "12 TABLET in 1 BOTTLE, PLASTIC (67296-2164-1)", "package_ndc": "67296-2164-1", "marketing_start_date": "20200413"}, {"sample": false, "description": "6 TABLET in 1 BOTTLE, PLASTIC (67296-2164-6)", "package_ndc": "67296-2164-6", "marketing_start_date": "20200413"}], "brand_name": "Buprenorphine and Naloxone", "product_id": "67296-2164_45abede5-7ceb-60e1-e063-6394a90a9a4a", "dosage_form": "TABLET", "pharm_class": ["Opioid Antagonist [EPC]", "Opioid Antagonists [MoA]", "Partial Opioid Agonist [EPC]", "Partial Opioid Agonists [MoA]"], "product_ndc": "67296-2164", "dea_schedule": "CIII", "generic_name": "Buprenorphine and Naloxone", "labeler_name": "Redpharm Drug", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Buprenorphine and Naloxone", "active_ingredients": [{"name": "BUPRENORPHINE HYDROCHLORIDE", "strength": "8 mg/1"}, {"name": "NALOXONE HYDROCHLORIDE DIHYDRATE", "strength": "2 mg/1"}], "application_number": "ANDA205601", "marketing_category": "ANDA", "marketing_start_date": "20200413", "listing_expiration_date": "20261231"}